Algorithm drops number of CTs for some strokes
An imaging algorithm reduced the number of CT angiography and CT perfusion studies performed on patients with aneurysmal subarachnoid hemorrhages, a form of stroke.
An imaging algorithm reduced the number of CT angiography and CT perfusion studies performed on patients with aneurysmal subarachnoid hemorrhages, a form of stroke. The study was performed by New York Presbyterian Hospital – Weill Cornell Medical Center researchers and included 60 patients.
The algorithm identifies the most appropriate points at which to detect vasospasm with CT angiography and CT perfusion imaging. A flow chart establishes imaging pathways and time frames.
With the new algorithm, the mean number of CT examinations per patient dropped from 7.8 to 5.8, a decrease of 25.6%, according to the investigators.
The number of CT perfusion exams per patient decreased 32.1% and overall cumulative radiation exposure decreased by 12.1%.
The results were published in the American Journal of Roentgenology (AJR 2010;195[1]:176-180).
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
